spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online December 22, 2004
doi: 10.1242/10.1242/jcs.01626


Journal of Cell Science 118, 1-6 (2005)
Published by The Company of Biologists 2005
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Connell, M. J.
Right arrow Articles by Cimprich, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Connell, M. J.
Right arrow Articles by Cimprich, K. A.

Commentary

G2 damage checkpoints: what is the turn-on?

Matthew J. O'Connell1,* and Karlene A. Cimprich2

1 Department of Oncological Sciences, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1130, New York, NY 10029, USA
2 Stanford University, Department of Molecular Pharmacology, 318 Campus Drive, Stanford, CA 94305, USA

* Author for correspondence (e-mail: matthew.oconnell{at}mssm.edu)

Cells mount a coordinated response to DNA damage, activating DNA repair pathways and cell-cycle checkpoint pathways to allow time for DNA repair to occur. In human cells, checkpoint responses can be divided into p53-dependent and p53-independent pathways, the latter being predominant in G2 phase of the cell cycle. The p53-independent pathway involves a phosphorylation cascade that activates the Chk1 effector kinase and induces G2 arrest through inhibitory tyrosine phosphorylation of Cdc2. At the top of this cascade are the ATR and ATM kinases. How ATM and ATR recognize DNA damage and activate this checkpoint pathway is only beginning to emerge. Single-stranded DNA, a result of stalled DNA replication or processing of chromosomal lesions, appears to be central to the activation of ATR. The recruitment of replication protein A to single-stranded DNA facilitates the recruitment of several complexes of checkpoint proteins. In this context, ATR is activated and then phosphorylates the C-terminus of Chk1, activating it to enforce a block to mitotic entry.

Key words: DNA damage, Cell-cycle checkpoint control, ATR, ATM, Chk1




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Yan, C. P. Black, P. T. Cao, J. L. Haferbier, R. H. Kolb, R. S. Spieker, A. M. Ristow, and K. H. Cowan
{gamma}-Irradiation-Induced DNA Damage Checkpoint Activation Involves Feedback Regulation between Extracellular Signal-Regulated Kinase 1/2 and BRCA1
Cancer Res., July 1, 2008; 68(13): 5113 - 5121.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Satyanarayana, M. B. Hilton, and P. Kaldis
p21 Inhibits Cdk1 in the Absence of Cdk2 to Maintain the G1/S Phase DNA Damage Checkpoint
Mol. Biol. Cell, January 1, 2008; 19(1): 65 - 77.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Errico, V. Costanzo, and T. Hunt
Tipin is required for stalled replication forks to resume DNA replication after removal of aphidicolin in Xenopus egg extracts
PNAS, September 18, 2007; 104(38): 14929 - 14934.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kosoy, T. M. Calonge, E. A. Outwin, and M. J. O'Connell
Fission Yeast Rnf4 Homologs Are Required for DNA Repair
J. Biol. Chem., July 13, 2007; 282(28): 20388 - 20394.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. H. Luo, K. Rosenke, K. Czornak, and E. A. Fortunato
Human Cytomegalovirus Disrupts both Ataxia Telangiectasia Mutated Protein (ATM)- and ATM-Rad3-Related Kinase-Mediated DNA Damage Responses during Lytic Infection
J. Virol., February 15, 2007; 81(4): 1934 - 1950.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
O. K. Mirzoeva, T. Kawaguchi, and R. O. Pieper
The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity.
Mol. Cancer Ther., November 1, 2006; 5(11): 2757 - 2766.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
Y. Hashimoto, T. Tsujimura, A. Sugino, and H. Takisawa
The phosphorylated C-terminal domain of Xenopus Cut5 directly mediates ATR-dependent activation of Chk1.
Genes Cells, September 1, 2006; 11(9): 993 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Taricani and T. S.F. Wang
Rad4TopBP1, a Scaffold Protein, Plays Separate Roles in DNA Damage and Replication Checkpoints and DNA Replication
Mol. Biol. Cell, August 1, 2006; 17(8): 3456 - 3468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. M. Karnitz, K. S. Flatten, J. M. Wagner, D. Loegering, J. S. Hackbarth, S. J. H. Arlander, B. T. Vroman, M. B. Thomas, Y.-U. Baek, K. M. Hopkins, et al.
Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival
Mol. Pharmacol., December 1, 2005; 68(6): 1636 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. Lee, D. A. Gold, A. Shevchenko, A. Shevchenko, and W. G. Dunphy
Roles of Replication Fork-interacting and Chk1-activating Domains from Claspin in a DNA Replication Checkpoint Response
Mol. Biol. Cell, November 1, 2005; 16(11): 5269 - 5282.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. Mesa, D. Loegering, H. L. Powell, K. Flatten, S. J. H. Arlander, N. T. Dai, M. P. Heldebrant, B. T. Vroman, B. D. Smith, J. E. Karp, et al.
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
Blood, July 1, 2005; 106(1): 318 - 327.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
L. M. Karnitz and S. J. H. Arlander
Chk1, a Novel Target to Sensitize Tumor Cells to Replication Inhibitors
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 254 - 257.
[Full Text] [PDF]




© The Company of Biologists Ltd 2005